| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |